Maven Securities »

Kyverna Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 146k 9.40

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics